Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 3: diagnosis
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Moderate
In people with bacteriologically confirmed pulmonary TB disease, targeted next generation sequencing technologies may be used on respiratory samples to diagnose resistance to isoniazid and pyrazinamide rather than culture-based phenotypic drug susceptibility testing
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed.
Year2024
InstitutionWorld Health Organization